Endoscopic Ultrasound- Guided Hartmann Reversal Procedure (EndoHARP)
Colorectal Neoplasms, Diverticular Diseases, Inflammatory Bowel Diseases
About this trial
This is an interventional treatment trial for Colorectal Neoplasms focused on measuring colorectal surgery, endotherapy, anastomosis, endoscopic ultrasound, gastrointestinal continuity, Hartmann procedure
Eligibility Criteria
Inclusion Criteria: participants of both sexes aged above 18 years participants, who provided informed consent for such treatment eligibility for Hartmann's procedure according to current medical knowledge based on evidence-based medicine. Exclusion Criteria: pregnancy, breastfeeding, or intention to become pregnant during the study contraindications to electrosurgical instruments allergy to any of the materials used in the study participants with advanced cancer in the metastatic stage participants ineligible for restoration of gastrointestinal continuity participants ineligible for surgery participants ineligible for general anesthesia
Sites / Locations
Arms of the Study
Arm 1
Experimental
Endoscopic Ultrasound- Guided Hartmann Reversal Procedure
Participants after Hartmann procedure, who were qualified and underwent Endoscopic Ultrasound- Guided Hartmann Reversal Procedure.